| scholarly article | Q13442814 |
| P50 | author | Thomas E. Starzl | Q1248240 |
| Marilyn M Wagener | Q106457841 | ||
| John Julian Fung | Q61476062 | ||
| P2093 | author name string | N Singh | |
| I R Marino | |||
| H Doyle | |||
| T Gayowski | |||
| P2860 | cites work | Positive pretransplant crossmatches predict early graft loss in liver allograft recipients | Q72262213 |
| A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation | Q34178497 | ||
| Disease gravity and urgency of need as guidelines for liver allocation | Q34232606 | ||
| Effect of donor age and sex on the outcome of liver transplantation | Q34248864 | ||
| Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report | Q34281070 | ||
| Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation | Q34286956 | ||
| The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors | Q34299410 | ||
| Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era | Q34340091 | ||
| Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? | Q34480423 | ||
| Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation | Q34498280 | ||
| Prioritization and organ distribution for liver transplantation | Q34546070 | ||
| The high-risk liver allograft recipient. Should allocation policy consider outcome? | Q36065644 | ||
| There is an answer to the shortage of organ donors. | Q37503483 | ||
| Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. | Q40949702 | ||
| Organ donor potential and performance: size and nature of the organ donor shortfall | Q40984441 | ||
| Pretransplant status and patient survival following liver transplantation | Q42672821 | ||
| Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa | Q42977701 | ||
| Stratifying the causes of death in liver transplant recipients. An approach to improving survival | Q45227894 | ||
| Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. | Q51016759 | ||
| Liver transplant candidate stratification systems. Implications for third-party payors and organ allocation. | Q53669533 | ||
| Preoperative risk factor assessment in liver transplantation | Q67913486 | ||
| Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants | Q71653205 | ||
| Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation | Q71961134 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver transplantation | Q1368191 |
| orthotopic liver transplantation | Q106649759 | ||
| P304 | page(s) | 499-504 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity | |
| P478 | volume | 65 |
| Q74127650 | Association of fungal infection and increased mortality in liver transplant recipients |
| Q38267664 | Cardiohepatic syndrome |
| Q59214654 | Cirrhotic cardiomyopathy |
| Q74127641 | Correlation between physiological assessment and outcome after liver transplantation |
| Q81904465 | Dysregulated expression of T-helper cell responses and susceptibility to infections in high-risk liver transplant recipients |
| Q30446573 | Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients |
| Q54741466 | Impact of dialysis and older age on survival after liver transplantation. |
| Q48829443 | Impact of the duration of posttransplant renal replacement therapy on bacterial infections in liver transplant recipients. |
| Q31107136 | Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group |
| Q46453032 | Infectious complications limit the outcome of liver transplantation in medical urgency code 2 patients |
| Q73304734 | Influence of donor age on the graft function after living-related liver transplantation |
| Q92574979 | Liver Transplantation and Early Culture Growth: Risk and Impact? |
| Q47912085 | Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations |
| Q45235441 | Negative impact of systemic catecholamine administration on hepatic blood perfusion after porcine liver transplantation |
| Q44401127 | Operative Parameters That Predict the Outcomes of Hepatic Transplantation |
| Q37328763 | Postoperative infectious complications of abdominal solid organ transplantation |
| Q35619736 | Predictive factors for early mortality following liver transplantation |
| Q44609931 | Short intensive care unit stay reduces septic complications and improves outcome after liver transplantation |
| Q40015439 | Spontaneous bacterial peritonitis is a risk factor for renal failure requiring dialysis in waitlisted liver transplant candidates. |
| Q34802534 | The new liver allocation system: moving toward evidence-based transplantation policy |
| Q43646693 | The risk factors of fungal infection in living-donor liver transplantations |
| Q39656292 | Timed Pediatric Risk of Mortality Scores predict outcomes in pediatric liver transplant recipients |
Search more.